Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.400
+0.018 (4.68%)
At close: Dec 20, 2024, 4:00 PM
0.399
-0.001 (-0.15%)
After-hours: Dec 20, 2024, 5:59 PM EST
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $16.52 million as of December 20, 2024. Its market cap has decreased by -72.01% in one year.
Market Cap
16.52M
Enterprise Value
-40.30M
1-Year Change
-72.01%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since the IPO on October 9, 2020, Spruce Biosciences's market cap has decreased from $333.95M to $16.52M, a decrease of -95.05%. That is a compound annual growth rate of -51.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 16.52M | -86.15% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 68.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unity Biotechnology | 16.34M |
| MEI Pharma | 16.33M |
| Traws Pharma | 16.14M |
| Synlogic | 16.04M |
| Nephros | 16.03M |
| The Oncology Institute | 15.63M |
| ProPhase Labs | 15.59M |
| Minerva Neurosciences | 14.97M |